The Effect of Uterine Manipulator Use During Abdominal Hysterectomy on Postoperative Sexual Function

A Prospective Randomized Controlled Trial Evaluating the Impact of Uterine Manipulator Use During Total Abdominal Hysterectomy on Postoperative Female Sexual Function

This prospective, single-center, randomized controlled trial aims to evaluate the effect of uterine manipulator use during total abdominal hysterectomy on postoperative female sexual function at 3 months, assessed by the Female Sexual Function Index (FSFI). Secondary outcomes include operative time, perioperative hemoglobin change, postoperative pain (VAS), hospital stay duration, and 30-day complications.

Inclusion Criteria:

• Women aged ≥18 years
• Planned total abdominal hysterectomy for benign indications
• Sexually active within the last 4 weeks
• Able to complete the Female Sexual Function Index (FSFI) questionnaire
• Provided written informed consent

Exclusion Criteria:

• Gynecologic malignancy
• Major additional pelvic reconstructive surgery
• Severe psychiatric or neurologic disorder
• Inability to complete follow-up assessments